MECP2 mutations account for most cases of typical forms of Rett syndrome
|
|
- Lindsey Pearson
- 6 years ago
- Views:
Transcription
1 2000 Oxford University Press Human Molecular Genetics, 2000, Vol. 9, No MECP2 mutations account for most cases of typical forms of Rett syndrome Thierry Bienvenu, Alain Carrié, Nicolas de Roux 1, Marie-Claude Vinet, Philippe Jonveaux 2, Philippe Couvert, Laurent Villard 3, Alexis Arzimanoglou 4, Cherif Beldjord, Michel Fontes 3, Marc Tardieu 5 and Jamel Chelly + Laboratoire de Génétique et Physiopathologie des retards mentaux ICGM, Faculté de Médecine Cochin, 24 rue du Faubourg Saint Jacques, Paris, France, 1 Laboratoire d Hormonologie et de Biologie Moléculaire, CHU Bicêtre, 78 rue du général Leclerc, Le Kremlin Bicêtre, France, 2 Laboratoire de Génétique, Hôpitaux de Brabois, rue du Morvan, Vandoeuvre Les Nancy, France, 3 INSERM U406, Faculté de la Timone, 27 boulevard Jean Moulin, Marseille Cedex, France, 4 Service de Neurologie Pédiatrique, Hôpital Robert Debré, 48 boulevard Sérurier, Paris, France and 5 Département de Pédiatrie, Service de Neurologie, CHU Bicêtre, 78 rue du général Leclerc, Le Kremlin Bicêtre, France Received 25 January 2000; Revised and Accepted 23 March 2000 Rett syndrome (RTT) is a severe progressive neurological disorder that affects almost exclusively females, with an estimated prevalence of approximately one in female births. Most cases are sporadic, but several reports about familial recurrence support X-linked dominant inheritance with male lethality. The gene responsible for this disorder, MECP2, was recently identified by candidate gene strategy. Mutations were detected in <25% of RTT cases in this first report. To characterize the spectrum of mutations in the MECP2 gene in RTT patients, we selected 46 typical RTT patients and performed mutation screening by denaturing gradient gel electrophoresis combined with direct sequencing. We identified 30 mutations, accounting for 65% of RTT patients. They include 12 novel mutations (11 located in exon 3 and one in exon 2). Mutations, such as R270X and frameshift deletions in a (CCACC) n rich region, have been found with multiple recurrences. Most of the mutations were de novo, except in one family where the non-affected transmitter mother exhibited a bias of X inactivation. Although this study showed that MECP2 mutations account for most cases of typical forms of RTT (65%) and mutations in non-coding regions cannot be excluded for the remaining cases, an alternative hypothesis that takes into account the homogeneous phenotype and exclusive involvement of females, could be the implication in RTT of a putative second X-linked gene. INTRODUCTION Rett syndrome (RTT) (MIM ) is a progressive encephalopathy which appears to affect females only. It was first described by Rett in 1966 (1,2). After normal development up to the age of 7 18 months, developmental stagnation occurred, followed by rapid deterioration of higher brain functions. RTT is characterized by severe mental retardation, autism, gait apraxia, hypotonia, disturbance of sleep and breathing, seizures, stereotypical hand movements and deceleration of head growth. Its prevalence is estimated at 1: female births. More than 95% of cases are sporadic, but rare reports of familial recurrence have been made. Previous exclusion mapping studies using the rare RTT families mapped the locus to Xq28 (3). Xq28 is a very gene-rich region and more than one syndrome with mental handicap and neurological signs and symptoms has already been identified within it. However, using a systematic gene screening approach, Zoghbi and colleagues (4) have identified mutations in the gene MECP2 encoding X-linked methyl-cpg-binding protein 2 as the cause of some cases of RTT (5/21 sporadic patients and 1/8 familial patients). More recently, they reported further data showing that MECP2 accounts for 50% of RTT (5). MeCP2 is an abundant chromosome-binding protein that selectively binds 5-methylcytosine residues in symmetrically positioned CpG dinucleotides in mammalian genomes (6). MeCP2 is rich in the basic residues lysine and arginine (22.5%) and in proline (11%) and serine (10.5%). MeCP2 contains two functional domains, an 85 amino acid methyl- CpG-binding domain (MBD), essential for its binding to 5- methylcytosine, and a 104 amino acid transcriptional repression domain (TRD) which interacts with histone deacetylase and the transcriptional corepressor Sin3A. Interactions between this transcription repressor complex and chromatinbound MeCP2 leads to deacetylation of core histones, which in turn leads to transcriptional repression. In the present study we have analysed the entire coding sequence of the MECP2 gene in a sample of 46 typical RTT sporadic cases. We have used the denaturing gradient gel electrophoresis (DGGE) assay combined with direct DNA sequencing and characterized 12 novel mutations. The sequence differences that were found clustered in the third + Towhomcorrespondenceshouldbeaddressed.Tel: ;Fax: ; chelly@icgm.cochin.inserm.fr
2 1378 Human Molecular Genetics, 2000, Vol. 9, No. 9 exon include recurrent nonsense, frameshift and missense mutations. Although the number of RTT patients investigated is not sufficient for statistical analysis, genotype phenotype correlations suggest the presence of a different frequency of some relevant symptoms, such as epilepsy, between the group of RTT patients with a mutated allele and the group of RTT patients with no mutation. RESULTS RTT patients and mutation screening of the MECP2 gene In this study we investigated MECP2 gene in 46 patients, exclusively girls, with a uniform and typical RTT according to the international criteria (see Materials and Methods) (1,7). To carry out mutation screening by DGGE, we have designed appropriate primers to analyse the three exons of the MECP2 gene, and for each amplified segment we determined the optimal position of the chemical clamps (8). The theoretical melting analysis of each fragment was determined by the computer program developed by Lerman and colleagues (9). Exon 2 was analysed in three PCR fragments named 2.1, 2.2 and 2.3, and exon 3 was analysed in five PCR fragments named 3A, 3B, 3C, 3D and 3E (Table 1). Amplification by PCR and DGGE analysis followed by direct sequencing of fragments exhibiting abnormal migration profiles were performed in 38 typical sporadic cases of RTT and their parents. In the remaining eight patients, mutation analysis was performed by direct sequencing of PCR products. In total, this investigation of the nine fragments covering the coding part of MECP2 gene identified in 30 unrelated RTT patients the presence of 17 different mutations mainly clustered in exon 3, and some of them appeared with multiple recurrences. Most of these mutations, which account for 65% of typical RTT cases, are novel and only five mutations have been described previously. Analysis of exon 1 of the MECP2 gene revealed the presence in one RTT sporadic case of an abnormal migration pattern of the PCR fragment corresponding to this exon. The sequence of the PCR product showed a C T substitution at cdna position 15 upstream of the AUG initiation codon. This change was also identified in her unaffected mother. This RTT patient also presents a stop mutation in exon 3 of the MECP2 gene, suggesting that this change (C T at position 15) is a nonpathogenic variant. Exon 2 revealed the presence in one typical RTT case of an abnormal migration pattern of the PCR fragment 2.2, which covers part of exon 2 (Fig. 1B). The sequence of the PCR
3 Human Molecular Genetics, 2000, Vol. 9, No Figure 1. (A) DGGE results corresponding to the fragment 3A of the MECP2 gene. Lane 1, T158M; lanes 2 4, normal; lane 5, R168X. (B) Novel missense MECP2 mutations in typical sporadic RTT patients. Portions of the displayed electrophoregrams illustrate three mutations in RTT patients: P302R, R106Q and 1461A C. The underlined nucleotides and arrows indicate mutated nucleotides for each patient. (C) Novel MECP2 nonsense and frameshift mutations in typical sporadic RTT patients. Portions of the displayed electrophoregrams illustrate five mutations found in RTT patients: R198X, R270X, R294X, 677insA and 1156del17. Deletion is indicated by bold type. The underlined nucleotides and arrows indicate mutated nucleotides for each patient. product of exon 2 revealed a C T substitution at position 317. This mutation, R106Q, is the second missense mutation identified in the first part of the MBD. Another mutation R106W was found previously in the same codon (4). In contrast to these rare events occurring in exons 1 and 2, DGGE screening of exon 3 of the MECP2 gene revealed the presence of different abnormal migration patterns of PCR fragments 3A, 3B, 3C and 3D corresponding to exon 3 (Fig. 1A). The sequences of the PCR products corresponding to fragments 3A 3D revealed five nonsense mutations [R168X (n = 3), R198X (n =1),R255X(n =2), R270X (n = 5) and R294X (n = 3)] (Fig. 1C), three missense mutations [T158M (n =3),P302R(n = 1) and R306C (n = 1)] (Fig. 1B), one insertion [677insA (n = 1)], four deletions [1156del17 (n = 1), 1158del10 (n = 1), 1163del26 (n = 1) and 1164del A T
4 1380 Human Molecular Genetics, 2000, Vol. 9, No. 9 Table 1. Parameters for amplification of the MECP2 gene fragments and for DGGE conditions Fragment Sequences of primers Length (bp) Annealing temp ( C) Gradient (%) Running time (h) at 160 V Exon 1 1F: 5'-Pso-tttctttgttttaggctcca-3' R: 5'-ggccaaaccaggacatatac-3' Exon F: 5'-atgtatgatgaccccaccct-3' R: 5'-Pso-ctgtagagataggagttgct-3' Exon F: 5'-gtgatacttacatacttgtt-3' R: 5'-Pso-ggctcagcagagtggtgggc-3' Exon F: 5'-Pso-gagcccgtgcagccatcagc-3' R: 5'-cgtgtccagccttcaggcag-3' Exon 3A 3AF: 5'-Pso-tgtgtctttctgtttgtccc-3' AR: 5'-gatttgggcttcttaggtgg-3' Exon 3B 3BF: 5'-Pso-cctcccggcgagagcagaaa-3' BR: 5'-tgacctgggtggatgtggtg-3' Exon 3C 3CF: 5'-tgccttttcaaacttcgcca-3' CR: 5'-Pso-tgaggaggcgctgctgctgc-3' Exon 3D 3DF: 5'-gcagcagcagcgcctcctca-3' DR: 5'-Pso-tggcaaccgcgggctgagtca-3' Exon 3E 3EF: 5'-Pso-tgccccaaggagccagctaa-3' ER: 5'-gctttgcaatccgctccgtg-3' Pso, psoralen TA (n = 1)] (Fig. 1B and C) and one silent polymorphism (S194S). The nonsense mutations were due most frequently (four out of five cases) to C T transitions occurring in CpG dinucleotides. All the genomic deletions resulted in a shift of the translation reading frame leading to a premature termination of MeCP2 synthesis. The screening of the PCR fragment 3E revealed the presence of an abnormal migration pattern of exon 3 in only one RTT sporadic case. The sequence revealed an A C substitution changing the normal TGA stop codon of the MECP2 gene to a TGC cysteine codon (Fig. 1B). This base-pair substitution was predicted to generate a MeCP2 protein of 513 amino acids, 27 amino acids longer than the normal protein. If the mutation destroys a unique restriction site, this event was used to study the segregation of the base substitution in the family of the patient (Table 2). In addition to these mutations revealed by DGGE screening, analysis of the MECP2 gene by direct sequencing in eight patients showed five additional mutations located also in exon 3 (R168X, R255X, R306C, P322A and 1194insT). We analysed DNA samples from both parents of all individuals with a MECP2 mutation and none of the parents samples showed any abnormalities by DGGE or restriction analysis, demonstrating that these are de novo mutations, except in one case. In one family with a RTT girl bearing the T158M mutation, we also found the same mutation in the unaffected mother, but not in the normal brother. This mutation has already been described by Amir et al. (4). This change may disrupt the structure of the MBD, thereby interfering with its function. The crucial role of this domain is suggested by the fact that deletion of residues from MeCP2, which corresponds to most of the hairpin loop, resulted in a total loss of methyl-cpg-binding activity (10). To clarify the discrepancy between the phenotype and the genotype in the mother, we analysed the X-inactivation pattern in this family. We used DNA prepared from peripheral blood leukocytes and assessed the X-chromosome inactivation pattern as described by Allen et al. (11) using PCR analysis of the androgen receptor gene, which contains two methylation-sensitive sites (HpaII and HhaI) flanking a polymorphic trinucleotide repeat in the first exon. Interestingly, we found that the patient s mother presented a totally skewed pattern of X inactivation (data not shown). In the affected girl, the analysis was not conclusive because the trinucleotide repeat marker was not informative. Although these analyses did not allow unambiguous demonstration that this mutation is deleterious and assessment of whether the mutated allele lies on the inactive X chromosome, it is reasonable to propose the skewed pattern of X inactivation as the likely event involved in the rescue of the mother phenotype. Genotype phenotype correlations We first focused on the group of patients with mutations in MECP2 and looked for phenotype genotype correlation, taking into account for the genotype the type of mutation (missense, nonsense or frameshift) and its position with respect to the functional domains and the 3' end of the open reading frame (ORF). This analysis did not show any significant correlation. We next compared the 30 patients (mean age ± 1 SD: 14.6 ± 5 years) who had a mutation in the MECP2 gene, with the 16 patients (mean age ± 1 SD: 13.5 ± 5 years; mutated versus nonmutated NS) who had no detected mutation for different clinical items obtained before the onset of the genetic study, as
5 Human Molecular Genetics, 2000, Vol. 9, No Table 2. Types of MECP2 mutation detected in RTT individuals Patient no. Base change Mutation Sibling investigation methods 1 808C T R270X NlaIV ( ) 2 317G A R106Q DGGE 3 808C T R270X DGGE; NlaIV ( ) 7 502C T R168X HhpI(+) 8 473C T T158M NlaIII (+) 9 502C T R168X HphI(+) C T R294X DGGE C T R306C HhaI( ) C T T158M NlaIII (+) del26 DGGE; MnlI ( ) A T R198X MaeII (+) C T R168X HphI(+) C T R306C HhaI( ) insT BspWI (+) C T T158M NlaIII (+) C T R255X DGGE del17 DGGE; MnlI ( ) C T R168X HphI(+) C G P302R SfaNI (+) C G P322A DraII (+) C T R270X DGGE; NlaIV ( ) C T R270X DGGE; NlaIV ( ) A C X487C Fnu4HI (+) C T R270X NlaIV ( ) insA DGGE C T R294X DGGE del26 DGGE; MnlI ( ) C T R294X DGGE C T R255X DGGE del10 DGGE; MnlI ( ) Mutations either create (+) or destroy ( ) the restriction site for the enzyme shown in the right column. described in Materials and Methods (2,7). The general characteristics of the families were similar in the two groups with a mean of 2.8 (mutated patients) and 2.3 (non-mutated) children per family. The repartition of sex among brothers and sisters was identical in the two groups but the female:male ratio in families with more than one child (including the propositus) was slightly skewed towards girls in both cases (62 versus 76% girls, mutated versus non-mutated). As expected in these patients pre-selected for having a typical case of RTT, the frequency of the most characteristic symptoms of RTT (normal initial development, acquired microcephaly, stereotypic hand movement, phase of social withdrawal, breathing dysfunction) were identical in both groups. Although statistically not significant, it is worth mentioning that the patients with detected mutation lost more frequently acquired purposeful hand skills (71 versus 50%, mutated versus non-mutated; P =0.15),had more frequent peripheral vasomotor disturbances (77 versus 50%; P = 0.33) and epilepsy (41 versus 23%; P =0.25)while they were more frequently able to walk (21 versus 55%; P = 0.24). DISCUSSION In order to evaluate the prevalence of RTT related to MECP2 mutations, we have carried out a systematic analysis of the MECP2 gene in 46 typical RTT patients and screened by DGGE (n = 38) and by direct sequencing (n = 8) the whole coding sequence of this gene. Upon analysis by DGGE of exon 1 to exon 3, and sequencing of PCR fragments exhibiting abnormal DGGE migration profiles, we have identified 25/38 (66%). Direct sequencing of the whole coding sequence revealed five of eight mutations (62.5%). Altogether, these analyses allowed identification of disease-causing MECP2 mutations in 65% (30/46) of typical RTT patients. Of these mutations, 12 were novel and clustered in the third exon of the MECP2 gene. Though all patients included in this study have homogeneous clinical phenotype and fulfilled the same diagnosis criteria, and the frequency of mutations in this gene is very high, no mutation was identified in 35% of the screened patients. Although investigations reported in this study cannot exclude the presence of mutations that might lie the 3'-UTR, promoter or intronic sequences, an alternative hypothesis, which takes into account the exclusive involvement of females, could be the involvement in RTT of a putative second X-linked gene. MeCP2 acts as a molecular link by binding to 5-methylcytosine with its MBD domain and to the corepressor Sin3A via its TRD, thus recruiting histone deacetylases and other proteins to the silencing complex. Therefore, X-linked genes encoding the different components of the histone deacetylase complex could be considered as reasonable potential candidate genes for RTT. These studies identified in 30/46 unrelated families 17 different mutations with independent de novo recurrences of most of them (Fig. 2; Table 2), five of these different mutations havealreadybeenreportedbyamiret al. (4)andWanet al. (5), and 12 are novel. Although the spectrum of mutations is very heterogeneous, occurrence of mutations mainly in exon 3, and the multiple recurrences of R270X (five times) and R168X (four times), R255X (twice) and R294X (twice), points to true mutational hotspots that could influence molecular diagnosis strategies of RTT. Including the data reported by Amir et al. (4) and Wan et al. (5), the spectrum of mutations now encompasses eight missense and 15 nonsense or frameshift mutations, including four small deletions, ranging from 10 to 26 bp and localized in the region of the coding sequence of the cdna (Fig. 2). As deletion events in human genes appear to be, at least in part, related to local DNA sequence environment (11), we examined carefully the sequence environment of the short deletions and identified four CCACC direct repeat sequences distributed over the region of interest which is also a very C-rich sequence (Fig. 3). This observation could be coherent with the previously reported model of slipped mispairing (12) as molecular basis for the occurrence of deletions. Among the molecular defects reported in this work, 11 are nonsense or frameshift mutations (R168X, R198X, 677insA,
6 1382 Human Molecular Genetics, 2000, Vol. 9, No. 9 Figure 2. Distribution of the mutations in the MECP2 gene along the coding sequence. Top, mutations identified in this study. Bottom, mutations described previously (4,11). Novel mutations described in this study are underlined. Figure 3. Sequence environment of the small deletions identified in the MECP2 gene. Deleted nucleotides are indicated by bold type. The CCACC direct repeats flanking and/or overlapping the MECP2 gene deletions are underlined. R255X, R270X, R294X, 1156del17, 1158del10, 1163del26, 1165del26 and 1194insT) leading to premature polypeptide chain termination. In contrast to conventional wisdom, mrnas that contain these mutations (also referred to as nonsense mrnas and chain-termination mutations, respectively) rarely produce truncated proteins. Most nonsense mrnas are highly unstable because they are degraded by a decay pathway called nonsense-mediated mrna decay (NMD) (13,14). This process, whereby mrnas are monitored for errors that arise during gene expression, has been found in several species, including human (15,16). Typically, chaintermination mutations that reduce mrna abundance by reducing the half-life of mrna behave like loss-of-function alleles, except in some cases (i.e. mutations near the 3' end of the ORF), where the RNA surveillance system is bypassed. Although most of the mutations described here are located in the first half of the coding region and should in theory trigger the NMD process, investigation of transcripts and proteins resulting from the diverse panel of mutations is still a relevant issue that might provide additional information about MecP2 functional domains. During this study, we identified three novel mutations causing amino acid substitutions. These three missense mutations, R106Q, P302R and P322A, are drastic amino acid changes at the protein level. Moreover, all these amino acids are conserved in human, mouse and Xenopus laevis (4). The R106Q mutation is located in the MBD of the protein. A mutation identified previously in this domain is located at the same codon (R106W) (4). These two amino acid substitutions may reduce or abolish methyl-cpg binding. The P322A mutation is located in a conserved C-terminus and the other missense mutation P302R is located at the end of the TRD. Replacement of proline by arginine or alanine may cause abnormal folding of the protein. All these base substitutions were absent in >100
7 Human Molecular Genetics, 2000, Vol. 9, No normal X chromosomes. Altogether, these data suggest that these DNA variants are disease-causing mutations rather than polymorphisms. In addition, we identified an original mutation in the termination codon. The 1461A C substitution was predicted to generate a MeCP2 protein of 513 amino acids (27 amino acids longer than the normal one). It has been reported previously that the abnormal mrna translation due to a mutation in the termination codon is associated with decreased mrna stability such that no mrna or protein synthesis from the mutant allele can be detected in cells (17). Although mutations identified are heterogeneous (17 different mutations in this study), nearly 65% of typical RTT individuals were found to have changes within the coding region of exon 3. In our population, the novel R270X nonsense mutation accounts for 16% of our RTT chromosomes. This finding suggests that initial analysis of this exon would provide the most efficient approach in a mutation detection protocol. Concerning the remaining 35% of typical RTT with no mutation in the coding sequence of the MECP2 gene, our further investigation will focus on the study of the 5'- and 3'-UTR combined with quantitative studies of MECP2 mrna. In addition, we will search for X-linked candidate genes required for methyl-cpg-binding protein complexes. MATERIALS AND METHODS Patients The 46 sporadic cases of RTT investigated in this study were issued from the French register established in To validate the diagnosis, we used the international criteria adopted by the Rett Syndrome Diagnostic Criteria Work Group (1,7). Briefly, for all patients, after normal general and psychomotor development up to the age of 7 18 months, development stagnation occurred, followed by rapid deterioration of higher brain functions. This deterioration led to severe dementia, autism, loss of purposeful use of the hands, jerky truncal ataxia and acquired microcephaly. Additional insidious neurological abnormalities, such as spastic parapareses, vasomotor disturbances of the lower limbs and epilepsy were also observed. For each case, the clinical status was first reviewed by a skilled and experienced neuropaediatrician and the diagnosis was graded as established, probable or possible. Independently, a questionnaire evaluating 50 items, including the necessary, supportive and exclusion criteria of the Rett Syndrome Diagnostic Criteria Work Group was completed by two specially trained investigators. At the same time, a blood sample of the patient and her family was obtained and a lymphoblastoid cell line was established with family consent. For different genetic studies (and well before the initiation of the present study), we selected patients who: (i) had an established clinical diagnosis of RTT; (ii) fulfilled more than seven of the nine necessary criteria in the questionnaire, at least one of the supportive criteria and none of the exclusion criteria; (iii) were >8 years old. These patients were tested in the present study. The χ 2 test was used to analyse the comparative frequency of the most characteristic symptoms of RTT in patients with detected mutation and in patients with no detected mutation. Mutation analysis Denaturing gradient gel electrophoresis (DGGE). DNA was extracted from peripheral blood leukocytes or lymphoblastoid cells, and the three exons and the flanking intronic sequences of the MECP2 gene were separately PCR-amplified from genomic DNA using primers listed in Table 1, with psoralen clamps. DGGE conditions were chosen according to the Meltmap program, kindly provided by L.Lerman and colleagues (9). The denaturants were 7 M and 40% formamide, and gels were run at 60 C (8,9). PCR products were subjected to electrophoresis as described in Table 1. Formal consents were obtained from the families for mutation screening. Mutation identification. PCR products showing an abnormal migration pattern on DGGE analysis were sequenced directly on an automated sequencer (ABI 373; Perkin Elmer, Foster City, CA) using the Dye Terminator method. Every sequence variation was checked by restriction analysis of genomic DNA. In eight typical RTT patients, screening of the whole coding sequence of the MECP2 gene has been performed by direct sequencing. ACKNOWLEDGEMENTS We thank the patients and the families for their contribution in this study. We also thank Genethon bank for providing DNA samples, and colleagues from the Société Française de Neuropédiatrie who participated to the diagnosis evaluation and allowed us to study their patients. This work was supported mainly by the Association Française du syndrome de Rett (ASFR). This work was also supported by grants from Institut National de la Santé et de la Recherche Médicale (INSERM), the Association Française contre les Myopathies (AFM), the Fondation Jerome Lejeune (FJL) and the Fondation pour la Recherche Médicale. REFERENCES 1. Rett, A. (1966) Ueber ein eigenartiges hirnatrophisches syndrom bei hyperammoniamie in kindesalter. Wien. Med. Wsch., 116, Hagberg, B., Aicardi, J., Dias, K. and Ramos, O. (1983) A progressive syndrome of autism, dementia, ataxia and loss of purposeful hand use in girls: Rett s syndrome: report of 35 cases. Ann. Neurol., 14, Webb, T., Clarke, A., Hanefeld, F., Pereira, J.L., Rosenbloom, L. and Woods, C.G. (1998) Linkage analysis in Rett syndrome families suggests that there may be a critical region at Xq28. J. Med. Genet., 33, Amir, R.E., Van den Veyver, I.B., Wan, M., Tran, C.Q., Francke, U. and Zoghbi, H.Y. (1999) Rett syndrome is caused by mutations in X-linked MECP2, encoding methyl-cpg-binding protein 2. Nature Genet., 23, Wan, M., Sung Jae Lee, S., Zhang, X., Houwink-Manville, I., Song, H.R., Amir, R.E., Budden, S., Naidu, S., Pereira, J.L.P. et al. (1999). Rett syndrome and beyond: recurrent spontaneous and familial MeCP2 mutations at CpG hotspots. Am.J.Hum.Genet., 65, Lewis, J.D., Meehan, R.R., Henzen, W.J., Maurer-Fogy, I., Jeppesen, P., Klein, P. and Bird, A. (1992) Purification, sequence and cellular localization of a novel chromosomal protein that binds to methylated DNA. Cell, 69, The Rett Syndrome Diagnostic Criteria Work Group (1988) Diagnostic criteria for Rett syndrome. Ann. Neurol., 23, Bienvenu, T., Cazeneuve, C., Kaplan, J.C. and Beldjord, C. (1995) Mutation heterogeneity of cystic fibrosis in France: screening by denaturing gradient gel electrophoresis using psoralen-modified oligonucleotide. Hum. Mutat., 6,
8 1384 Human Molecular Genetics, 2000, Vol. 9, No Myers, R.M., Maniatis, T. and Lerman, L.S. (1987) Detection and localisation of single base changes by denaturing gradient gel electrophoresis. Methods Enzymol., 155, Nan, X., Meehan, R.R. and Bird, A. (1993) Dissection of the methyl-cpg binding domain from the chromosomal protein MeCP2. Nucleic Acids Res., 21, Allen, R.C., Zoghbi, H.Y., Moseley, A.B., Rosenblatt, H.M. and Belmont, J.W. (1992) Methylation of HpaII and HhaI sites near the polymorphic CAG repeat in the human androgen-receptor gene correlates with X chromosome inactivation. Am.J.Hum.Genet., 51, Cooper, D.N. and Krawczak, M. (1993) Human Gene Mutation. BIOS Scientific Publishers Limited, Oxford, UK. 13. Leeds, P., Peltz, S.W., Jacobson, A. and Culbertson, M.R. (1992) The product of the yeast UPF1 gene is required for rapid turnover of mrnas containing a premature translational termination codon. Genes Dev., 5, Leeds, P., Wood, J.M., Lee, B.S. and Culbertson, M.R. (1992) Gene products that promote mrna turnover in Saccharomyces cerevisiae. Mol. Cell. Biol., 12, Applequist, S.E., Selg, M., Raman, C. and Jack, H.M. (1996) Cloning and characterization of hupf1, a human homolog of the Saccharomyces cerevisiae non-sense mrna-reducing UPF1 protein. Nucleic Acids Res., 25, Sun, X., Perlick, H.A., Dietz, H.C. and Maquat, L.E. (1998) A mutated human homologue to yeast Upf1 protein has a dominant-negative effect on the decay of non-sense-containing mrnas in mammalian cells. Proc. Natl Acad. Sci. USA, 95, Hunt, D.M., Higgs, D.R., Winichagoon, P., Clegg, J.B. and Weatherall, D.J. (1982) Haemoglobin constant Spring has an unstable a chain messanger RNA. Br. J. Haematol., 51,
ABSTRACT. Downloaded by Guangxi University for Nationalities from online.liebertpub.com at 02/27/18. For personal use only.
GENETIC TESTING Volume, Number, 00 Mary Ann Liebert, Inc. Spectrum of MECP Mutations in Rett Syndrome The French Consortium for MECP Gene Analysis: THIERRY BIENVENU, LAURENT VILLARD, NICOLAS DE ROUX, VIOLAINE
More informationParental origin of de novo MECP2 mutations in Rett syndrome
(2001) 9, 231 ± 236 ã 2001 Nature Publishing Group All rights reserved 1018-4813/01 $15.00 www.nature.com/ejhg SHORT REPORT Parental origin of de novo MECP2 mutations in Rett syndrome Muriel Girard 1,
More informationObjectives. Genetics and Rett syndrome: As easy as apple pie! Chromosome to gene to protein
Genetics and Rett syndrome: As easy as apple pie! Victoria Mok Siu M.D., FRCPC, FCCMG ORSA conference Ottawa April 24, 2016 Objectives Review chromosomes and genes Understand s Explore the reasons behind
More informationRett syndrome and the MECP2 gene
J Med Genet 2001;38:217 223 217 Review article Section of Medical and Molecular Genetics, Division of Reproductive and Child Health, University of Birmingham, Birmingham, UK T Webb F Latif Correspondence
More informationX chromosome inactivation patterns in brain in Rett syndrome: implications for the disease phenotype
Brain & Development 27 (2005) 266 270 Original article X chromosome inactivation patterns in brain in Rett syndrome: implications for the disease phenotype Joanne H. Gibson a,b, Sarah L. Williamson a,b,
More informationBio 111 Study Guide Chapter 17 From Gene to Protein
Bio 111 Study Guide Chapter 17 From Gene to Protein BEFORE CLASS: Reading: Read the introduction on p. 333, skip the beginning of Concept 17.1 from p. 334 to the bottom of the first column on p. 336, and
More informationAlpha thalassemia mental retardation X-linked. Acquired alpha-thalassemia myelodysplastic syndrome
Alpha thalassemia mental retardation X-linked Acquired alpha-thalassemia myelodysplastic syndrome (Alpha thalassemia mental retardation X-linked) Acquired alpha-thalassemia myelodysplastic syndrome Schematic
More informationMeCP2 mutations in children with and without the phenotype of Rett syndrome
MeCP2 mutations in children with and without the phenotype of Rett syndrome K. Hoffbuhr, PhD; J.M. Devaney, PhD; B. LaFleur, PhD, MPH; N. Sirianni, MS; C. Scacheri, MS; J. Giron, BS; J. Schuette, MS; J.
More informationMolecular Biology (BIOL 4320) Exam #2 May 3, 2004
Molecular Biology (BIOL 4320) Exam #2 May 3, 2004 Name SS# This exam is worth a total of 100 points. The number of points each question is worth is shown in parentheses after the question number. Good
More informationKeywords: Rett syndrome; skewed X chromosome inactivation; X chromosome; MECP2
J Med Genet ;8:5 5 INSERM U9, Faculté de Médecine, 7 Bd Jean Moulin, 85 Marseille Cedex 5, France L Villard N Lévy A Kpebe C E Schwartz M Fontès Département de Génétique Médicale, Laboratoire de Génétique
More informationIVF Michigan, Rochester Hills, Michigan, and Reproductive Genetics Institute, Chicago, Illinois
FERTILITY AND STERILITY VOL. 80, NO. 4, OCTOBER 2003 Copyright 2003 American Society for Reproductive Medicine Published by Elsevier Inc. Printed on acid-free paper in U.S.A. CASE REPORTS Preimplantation
More informationCorporate Medical Policy
Corporate Medical Policy File Name: Origination: Last CAP Review: Next CAP Review: Last Review: genetic_testing_for_rett_syndrome 7/2012 3/2017 3/2018 5/2017 Description of Procedure or Service Rett syndrome
More informationLarge Genomic Rearrangements in MECP2
HUMAN MUTATION Mutation in Brief #791 (2005) Online MUTATION IN BRIEF Large Genomic Rearrangements in MECP2 Kirstine Ravn 1 *, Jytte Bieber Nielsen 2, Ola Husbeth Skjeldal 3, Alison Kerr 4, Maj Hulten
More informationSpectrum of MECP2 mutations in Vietnamese patients with RETT syndrome
Le Thi Thanh et al. BMC Medical Genetics (2018) 19:137 https://doi.org/10.1186/s12881-018-0658-x RESEARCH ARTICLE Open Access Spectrum of MECP2 mutations in Vietnamese patients with RETT syndrome Huong
More informationJULY 21, Genetics 101: SCN1A. Katie Angione, MS CGC Certified Genetic Counselor CHCO Neurology
JULY 21, 2018 Genetics 101: SCN1A Katie Angione, MS CGC Certified Genetic Counselor CHCO Neurology Disclosures: I have no financial interests or relationships to disclose. Objectives 1. Review genetic
More informationDiagnostic Testing for Rett Syndrome by DHPLC and Direct Sequencing Analysis of the MECP2
Am. J. Hum. Genet. 67:1428 1436, 2000 Diagnostic Testing for Rett Syndrome by DHPLC and Direct Sequencing Analysis of the MECP2 Gene: Identification of Several Novel Mutations and Polymorphisms Inge M.
More informationMECP2 Mutations in Sporadic Cases of Rett Syndrome Are Almost Exclusively of Paternal Origin
Am. J. Hum. Genet. 68:1093 1101, 2001 MECP2 Mutations in Sporadic Cases of Rett Syndrome Are Almost Exclusively of Paternal Origin R. Trappe, 1,* F. Laccone, 1,* J. Cobilanschi, 1 M. Meins, 1 P. Huppke,
More informationIntroduction to Genetics
Introduction to Genetics Table of contents Chromosome DNA Protein synthesis Mutation Genetic disorder Relationship between genes and cancer Genetic testing Technical concern 2 All living organisms consist
More informationSupplemental Data: Detailed Characteristics of Patients with MKRN3. Patient 1 was born after an uneventful pregnancy. She presented in our
1 2 Supplemental Data: Detailed Characteristics of Patients with MKRN3 Mutations 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 Patient 1 was born after an uneventful pregnancy. She presented
More informationMutations and Disease Mutations in the Myosin Gene
Biological Sciences Initiative HHMI Mutations and Disease Mutations in the Myosin Gene Goals Explore how mutations can lead to disease using the myosin gene as a model system. Explore how changes in the
More informationSection Chapter 14. Go to Section:
Section 12-3 Chapter 14 Go to Section: Content Objectives Write these Down! I will be able to identify: The origin of genetic differences among organisms. The possible kinds of different mutations. The
More informationNovel RNAs along the Pathway of Gene Expression. (or, The Expanding Universe of Small RNAs)
Novel RNAs along the Pathway of Gene Expression (or, The Expanding Universe of Small RNAs) Central Dogma DNA RNA Protein replication transcription translation Central Dogma DNA RNA Spliced RNA Protein
More informationBeta Thalassemia Case Study Introduction to Bioinformatics
Beta Thalassemia Case Study Sami Khuri Department of Computer Science San José State University San José, California, USA sami.khuri@sjsu.edu www.cs.sjsu.edu/faculty/khuri Outline v Hemoglobin v Alpha
More informationProteins. Length of protein varies from thousands of amino acids to only a few insulin only 51 amino acids
Proteins Protein carbon, hydrogen, oxygen, nitrogen and often sulphur Length of protein varies from thousands of amino acids to only a few insulin only 51 amino acids During protein synthesis, amino acids
More informationIdentification of a novel duplication mutation in the VHL gene in a large Chinese family with Von Hippel-Lindau (VHL) syndrome
Identification of a novel duplication mutation in the VHL gene in a large Chinese family with Von Hippel-Lindau (VHL) syndrome L.H. Cao 1, B.H. Kuang 2, C. Chen 1, C. Hu 2, Z. Sun 1, H. Chen 2, S.S. Wang
More informationIs Intrinsic Hyperexcitability in CA3 the Culprit for Seizures in Rett Syndrome?
Current Literature In Basic Science Is Intrinsic Hyperexcitability in CA3 the Culprit for Seizures in Rett Syndrome? Network Hyperexcitability in Hippocampal Slices From Mecp2 Mutant Mice Revealed by Voltage-Sensitive
More informationMuscular Dystrophy. Biol 405 Molecular Medicine
Muscular Dystrophy Biol 405 Molecular Medicine Duchenne muscular dystrophy Duchenne muscular dystrophy is a neuromuscular disease that occurs in ~ 1/3,500 male births. The disease causes developmental
More informationTRANSLATION: 3 Stages to translation, can you guess what they are?
TRANSLATION: Translation: is the process by which a ribosome interprets a genetic message on mrna to place amino acids in a specific sequence in order to synthesize polypeptide. 3 Stages to translation,
More information8 Suppression Analysis
Genetic Techniques for Biological Research Corinne A. Michels Copyright q 2002 John Wiley & Sons, Ltd ISBNs: 0-471-89921-6 (Hardback); 0-470-84662-3 (Electronic) 8 Suppression Analysis OVERVIEW Suppression
More informationProblem Set 5 KEY
2006 7.012 Problem Set 5 KEY ** Due before 5 PM on THURSDAY, November 9, 2006. ** Turn answers in to the box outside of 68-120. PLEASE WRITE YOUR ANSWERS ON THIS PRINTOUT. 1. You are studying the development
More informationCANCER GENETICS PROVIDER SURVEY
Dear Participant, Previously you agreed to participate in an evaluation of an education program we developed for primary care providers on the topic of cancer genetics. This is an IRB-approved, CDCfunded
More informationvariant led to a premature stop codon p.k316* which resulted in nonsense-mediated mrna decay. Although the exact function of the C19L1 is still
157 Neurological disorders primarily affect and impair the functioning of the brain and/or neurological system. Structural, electrical or metabolic abnormalities in the brain or neurological system can
More informationREGULATED SPLICING AND THE UNSOLVED MYSTERY OF SPLICEOSOME MUTATIONS IN CANCER
REGULATED SPLICING AND THE UNSOLVED MYSTERY OF SPLICEOSOME MUTATIONS IN CANCER RNA Splicing Lecture 3, Biological Regulatory Mechanisms, H. Madhani Dept. of Biochemistry and Biophysics MAJOR MESSAGES Splice
More informationAdvances in genetic diagnosis of neurological disorders
Acta Neurol Scand 2014: 129 (Suppl. 198): 20 25 DOI: 10.1111/ane.12232 2014 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd ACTA NEUROLOGICA SCANDINAVICA Review Article Advances in genetic diagnosis
More informationClinical Spectrum and Genetic Mechanism of GLUT1-DS. Yasushi ITO (Tokyo Women s Medical University, Japan)
Clinical Spectrum and Genetic Mechanism of GLUT1-DS Yasushi ITO (Tokyo Women s Medical University, Japan) Glucose transporter type 1 (GLUT1) deficiency syndrome Mutation in the SLC2A1 / GLUT1 gene Deficiency
More informationAn exploration of the use of eye gaze & gestures in females with Rett syndrome. Anna Urbanowicz
An exploration of the use of eye gaze & gestures in females with Rett syndrome Anna Urbanowicz a.urbanowicz@uq.edu.au Background Communication Critical to participation in everyday life Challenging for
More informationFEP Medical Policy Manual
FEP Medical Policy Manual Effective Date: October 15, 2018 Related Policies: None Genetic Testing for Rett Syndrome Description Rett syndrome (RTT), a neurodevelopmental disorder, is usually caused by
More informationChoice making in Rett syndrome: A descriptive study using video data. Anna Urbanowicz
Choice making in Rett syndrome: A descriptive study using video data Anna Urbanowicz a.urbanowicz@uq.edu.au Background Diagnostic criteria for Rett syndrome Main criteria A period of regression: Loss of
More informationMUTATIONS, MUTAGENESIS, AND CARCINOGENESIS
MUTATIONS, MUTAGENESIS, AND CARCINOGENESIS How do different alleles arise? ( allele : form of a gene; specific base sequence at a site on DNA) Mutations: heritable changes in genes Mutations occur in DNA
More informationFunctional insights from genetic channelopathies Stephanie Schorge
Functional Insights From Genetic Channelopathies Dr. 1 Royal Society University Research Fellow Department of Clinical and Experimental Epilepsy Aims of channelopathies lecture Describe channelopathies
More informationSo-called cryptogenic partial seizures resulting from a subtle cortical dysgenesis due to a doublecortin gene mutation
Seizure 2002; 11: 273 277 doi:10.1053/seiz.2001.0607, available online at http://www.idealibrary.com on So-called cryptogenic partial seizures resulting from a subtle cortical dysgenesis due to a doublecortin
More informationMEDICAL GENOMICS LABORATORY. Next-Gen Sequencing and Deletion/Duplication Analysis of NF1 Only (NF1-NG)
Next-Gen Sequencing and Deletion/Duplication Analysis of NF1 Only (NF1-NG) Ordering Information Acceptable specimen types: Fresh blood sample (3-6 ml EDTA; no time limitations associated with receipt)
More informationBasic Definitions. Dr. Mohammed Hussein Assi MBChB MSc DCH (UK) MRCPCH
Basic Definitions Chromosomes There are two types of chromosomes: autosomes (1-22) and sex chromosomes (X & Y). Humans are composed of two groups of cells: Gametes. Ova and sperm cells, which are haploid,
More informationOverview: Conducting the Genetic Orchestra Prokaryotes and eukaryotes alter gene expression in response to their changing environment
Overview: Conducting the Genetic Orchestra Prokaryotes and eukaryotes alter gene expression in response to their changing environment In multicellular eukaryotes, gene expression regulates development
More informationMRC-Holland MLPA. Description version 29; 31 July 2015
SALSA MLPA probemix P081-C1/P082-C1 NF1 P081 Lot C1-0114. As compared to the previous B2 version (lot 0813 and 0912), 11 target probes are replaced or added, and 10 new reference probes are included. P082
More informationAre there foreseeable applications of genomic medicine for the management of neuropsychiatric conditions?
Are there foreseeable applications of genomic medicine for the management of neuropsychiatric conditions? Angus Clarke, Medical Genetics, Cardiff University, Wales Are there foreseeable applications of
More informationGenetic Disorders. SCPA 501: General Pathology. Amornrat Naranuntarat Jensen
Genetic Disorders SCPA 501: General Pathology Amornrat Naranuntarat Jensen amornrat.nar@mahidol.ac.th Human has 46 chromosomes (23 pairs) Sex chromosomes Human genome contains approximately 3 billion base
More informationGeorge R. Honig Junius G. Adams III. Human Hemoglobin. Genetics. Springer-Verlag Wien New York
George R. Honig Junius G. Adams III Human Hemoglobin Genetics Springer-Verlag Wien New York George R. Honig, M.D., Ph.D. Professor and Head Department of Pediatrics, College of Medicine University of Illinois
More informationRegulation of Gene Expression in Eukaryotes
Ch. 19 Regulation of Gene Expression in Eukaryotes BIOL 222 Differential Gene Expression in Eukaryotes Signal Cells in a multicellular eukaryotic organism genetically identical differential gene expression
More informationChapter 11 Gene Expression
Chapter 11 Gene Expression 11-1 Control of Gene Expression Gene Expression- the activation of a gene to form a protein -a gene is on or expressed when it is transcribed. -cells do not always need to produce
More informationClinical and Molecular Genetic Spectrum of Slovenian Patients with CGD
Clinical and Molecular Genetic Spectrum of Slovenian Patients with CGD Avčin T, Debeljak M, Markelj G, Anderluh G*, Glavnik V, Kuhar M University Children s Hospital Ljubljana and *Biotechnical Faculty,
More informationThe Human Major Histocompatibility Complex
The Human Major Histocompatibility Complex 1 Location and Organization of the HLA Complex on Chromosome 6 NEJM 343(10):702-9 2 Inheritance of the HLA Complex Haplotype Inheritance (Family Study) 3 Structure
More informationThis is an Open Access document downloaded from ORCA, Cardiff University's institutional repository:
This is an Open Access document downloaded from ORCA, Cardiff University's institutional repository: http://orca.cf.ac.uk/102603/ This is the author s version of a work that was submitted to / accepted
More informationCentral Dogma. Central Dogma. Translation (mrna -> protein)
Central Dogma Central Dogma Translation (mrna -> protein) mrna code for amino acids 1. Codons as Triplet code 2. Redundancy 3. Open reading frames 4. Start and stop codons 5. Mistakes in translation 6.
More informationChapter 12-4 DNA Mutations Notes
Chapter 12-4 DNA Mutations Notes I. Mutations Introduction A. Definition: Changes in the DNA sequence that affect genetic information B. Mutagen= physical or chemical agent that interacts with DNA to cause
More informationMMB (MGPG) Non traditional Inheritance Epigenetics. A.Turco
MMB (MGPG) 2017 Non traditional Inheritance Epigenetics A.Turco NON TRADITIONAL INHERITANCE EXCEPTIONS TO MENDELISM - Genetic linkage (2 loci close to each other) - Complex or Multifactorial Disease (MFD)
More informationCircular RNAs (circrnas) act a stable mirna sponges
Circular RNAs (circrnas) act a stable mirna sponges cernas compete for mirnas Ancestal mrna (+3 UTR) Pseudogene RNA (+3 UTR homolgy region) The model holds true for all RNAs that share a mirna binding
More informationSALSA MLPA KIT P050-B2 CAH
SALSA MLPA KIT P050-B2 CAH Lot 0510, 0909, 0408: Compared to lot 0107, extra control fragments have been added at 88, 96, 100 and 105 nt. The 274 nt probe gives a higher signal in lot 0510 compared to
More informationRECAP (1)! In eukaryotes, large primary transcripts are processed to smaller, mature mrnas.! What was first evidence for this precursorproduct
RECAP (1) In eukaryotes, large primary transcripts are processed to smaller, mature mrnas. What was first evidence for this precursorproduct relationship? DNA Observation: Nuclear RNA pool consists of
More informationTumor suppressor genes D R. S H O S S E I N I - A S L
Tumor suppressor genes 1 D R. S H O S S E I N I - A S L What is a Tumor Suppressor Gene? 2 A tumor suppressor gene is a type of cancer gene that is created by loss-of function mutations. In contrast to
More informationEukaryotic Gene Regulation
Eukaryotic Gene Regulation Chapter 19: Control of Eukaryotic Genome The BIG Questions How are genes turned on & off in eukaryotes? How do cells with the same genes differentiate to perform completely different,
More informationBio 100 Guide 08.
Bio 100 Guide 08 http://images.andrewsmcmeel.com/media/3820/medium.jpg http://www.biology.iupui.edu/biocourses/n100/images/11nondisjunction.gif http://www.unm.edu/~vscience/images/hela%20karyotype%203%20(1000x).jpg
More informationMRC-Holland MLPA. Description version 30; 06 June 2017
SALSA MLPA probemix P081-C1/P082-C1 NF1 P081 Lot C1-0517, C1-0114. As compared to the previous B2 version (lot B2-0813, B2-0912), 11 target probes are replaced or added, and 10 new reference probes are
More informationCANCER. Inherited Cancer Syndromes. Affects 25% of US population. Kills 19% of US population (2nd largest killer after heart disease)
CANCER Affects 25% of US population Kills 19% of US population (2nd largest killer after heart disease) NOT one disease but 200-300 different defects Etiologic Factors In Cancer: Relative contributions
More informationProposal form for the evaluation of a genetic test for NHS Service Gene Dossier
Proposal form for the evaluation of a genetic test for NHS Service Gene Dossier Test Disease Population Triad Disease name Loeys-Dietz Syndrome OMIM number for disease 609192; 608967; 610380; 610168 Disease
More informationMRC-Holland MLPA. Description version 29;
SALSA MLPA KIT P003-B1 MLH1/MSH2 Lot 1209, 0109. As compared to the previous lots 0307 and 1006, one MLH1 probe (exon 19) and four MSH2 probes have been replaced. In addition, one extra MSH2 exon 1 probe,
More informationInterrogating Rett Syndrome: developing ideas for research that matters. Angus Clarke, Clinical Genetics, Prifysgol Caerdydd, Cymru
Interrogating Rett Syndrome: developing ideas for research that matters Angus Clarke, Clinical Genetics, Prifysgol Caerdydd, Cymru Research into Rett Syndrome Four Factors: Unique clinical entity Biology
More informationIdentification and characterization of multiple splice variants of Cdc2-like kinase 4 (Clk4)
Identification and characterization of multiple splice variants of Cdc2-like kinase 4 (Clk4) Vahagn Stepanyan Department of Biological Sciences, Fordham University Abstract: Alternative splicing is an
More informationSALSA MLPA KIT P060-B2 SMA
SALSA MLPA KIT P6-B2 SMA Lot 111, 511: As compared to the previous version B1 (lot 11), the 88 and 96 nt DNA Denaturation control fragments have been replaced (QDX2). Please note that, in contrast to the
More informationNon-Mendelian inheritance
Non-Mendelian inheritance Focus on Human Disorders Peter K. Rogan, Ph.D. Laboratory of Human Molecular Genetics Children s Mercy Hospital Schools of Medicine & Computer Science and Engineering University
More informationComputational Systems Biology: Biology X
Bud Mishra Room 1002, 715 Broadway, Courant Institute, NYU, New York, USA L#4:(October-0-4-2010) Cancer and Signals 1 2 1 2 Evidence in Favor Somatic mutations, Aneuploidy, Copy-number changes and LOH
More informationThe Molecular Evolution of Gene Birth and Death. Author: Ann Brokaw AP Biology Teacher Rocky River High School Rocky River, Ohio
The Molecular Evolution of Gene Birth and Death Author: Ann Brokaw AP Biology Teacher Rocky River High School Rocky River, Ohio The Birth and Death of Genes To the student: The following slides provide
More informationA Comprehensive Study of TP53 Mutations in Chronic Lymphocytic Leukemia: Analysis of 1,287 Diagnostic CLL Samples
A Comprehensive Study of TP53 Mutations in Chronic Lymphocytic Leukemia: Analysis of 1,287 Diagnostic CLL Samples Sona Pekova, MD., PhD. Chambon Ltd., Laboratory for molecular diagnostics, Prague, Czech
More informationGenetics and Genomics in Medicine Chapter 6 Questions
Genetics and Genomics in Medicine Chapter 6 Questions Multiple Choice Questions Question 6.1 With respect to the interconversion between open and condensed chromatin shown below: Which of the directions
More informationVariant Classification. Author: Mike Thiesen, Golden Helix, Inc.
Variant Classification Author: Mike Thiesen, Golden Helix, Inc. Overview Sequencing pipelines are able to identify rare variants not found in catalogs such as dbsnp. As a result, variants in these datasets
More informationA suppressor locus for MODY3-diabetes
A suppressor locus for MODY3-diabetes Miguel A. Garcia-Gonzalez 1,2, Claire Carette 1,3, Alessia Bagattin 1, Magali Chiral 1, Munevver Parla Makinistoglu 1, Serge Garbay 1, Géraldine Prévost 4, Cécile
More informationLecture: Variability. Different types of variability in Biology and Medicine. Cytological essentials of heritable diseases. Plan of the lecture
Lecture: Variability. Different types of variability in Biology and Medicine. Cytological essentials of heritable diseases Plan of the lecture 1. Notion of variability. Different types of variability.
More informationIntroduction retroposon
17.1 - Introduction A retrovirus is an RNA virus able to convert its sequence into DNA by reverse transcription A retroposon (retrotransposon) is a transposon that mobilizes via an RNA form; the DNA element
More informationLack of Association between Endoplasmic Reticulum Stress Response Genes and Suicidal Victims
Kobe J. Med. Sci., Vol. 53, No. 4, pp. 151-155, 2007 Lack of Association between Endoplasmic Reticulum Stress Response Genes and Suicidal Victims KAORU SAKURAI 1, NAOKI NISHIGUCHI 2, OSAMU SHIRAKAWA 2,
More informationIntroduction to genetic variation. He Zhang Bioinformatics Core Facility 6/22/2016
Introduction to genetic variation He Zhang Bioinformatics Core Facility 6/22/2016 Outline Basic concepts of genetic variation Genetic variation in human populations Variation and genetic disorders Databases
More informationCh. 18 Regulation of Gene Expression
Ch. 18 Regulation of Gene Expression 1 Human genome has around 23,688 genes (Scientific American 2/2006) Essential Questions: How is transcription regulated? How are genes expressed? 2 Bacteria regulate
More informationLetters to the Editor
Am. J. Hum. Genet. 63:1552 1558, 1998 Letters to the Editor Am. J. Hum. Genet. 63:1552, 1998 Rett Syndrome: Confirmation of X-Linked Dominant Inheritance, and Localization of the Gene to Xq28 To the Editor:
More informationGenome - Wide Linkage Mapping
Biological Sciences Initiative HHMI Genome - Wide Linkage Mapping Introduction This activity is based on the work of Dr. Christine Seidman et al that was published in Circulation, 1998, vol 97, pgs 2043-2048.
More informationT4-BINDING globulin (TBG) is a 54-kDa glycoprotein
0021-972X/98/$03.00/0 Vol. 83, No. 10 Journal of Clinical Endocrinology and Metabolism Printed in U.S.A. Copyright 1998 by The Endocrine Society Complete Thyroxine-Binding Globulin (TBG) Deficiency Produced
More informationOriginal article. 1. Introduction
Brain & Development 23 (2001) S246 S250 Original article www.elsevier.com/locate/braindev MECP2 gene mutation analysis in the British and Italian Rett Syndrome patients: hot spot map of the most recurrent
More informationDNA methylation & demethylation
DNA methylation & demethylation Lars Schomacher (Group Christof Niehrs) What is Epigenetics? Epigenetics is the study of heritable changes in gene expression (active versus inactive genes) that do not
More informationMRC-Holland MLPA. Description version 19;
SALSA MLPA probemix P6-B2 SMA Lot B2-712, B2-312, B2-111, B2-511: As compared to the previous version B1 (lot B1-11), the 88 and 96 nt DNA Denaturation control fragments have been replaced (QDX2). SPINAL
More informationRNA and Protein Synthesis Guided Notes
RNA and Protein Synthesis Guided Notes is responsible for controlling the production of in the cell, which is essential to life! o DNARNAProteins contain several thousand, each with directions to make
More informationMutations. A2 Biology For WJEC
12. Mutation is a change in the amount, arrangement or structure in the DNA of an organism. 13. There are two types of mutations, chromosome mutations and gene mutations. Mutations A2 Biology For WJEC
More informationSEX-LINKED INHERITANCE. Dr Rasime Kalkan
SEX-LINKED INHERITANCE Dr Rasime Kalkan Human Karyotype Picture of Human Chromosomes 22 Autosomes and 2 Sex Chromosomes Autosomal vs. Sex-Linked Traits can be either: Autosomal: traits (genes) are located
More informationJayanti Tokas 1, Puneet Tokas 2, Shailini Jain 3 and Hariom Yadav 3
Jayanti Tokas 1, Puneet Tokas 2, Shailini Jain 3 and Hariom Yadav 3 1 Department of Biotechnology, JMIT, Radaur, Haryana, India 2 KITM, Kurukshetra, Haryana, India 3 NIDDK, National Institute of Health,
More informationEpigenetics and Human Disease
Epigenetics and Human Disease May 28, 2014 1 Angelman Syndrome & Prader-Willi Syndrome Sister Syndromes Angelman Syndrome ~1/20,000 births happy disposition smile often bouts of laughter minimal verbal
More informationBio 105 Guide 08.
Bio 105 Guide 08 http://images.andrewsmcmeel.com/media/3820/medium.jpg The chromosomes present in 1 cell nucleus! http://www.unm.edu/~vscience/images/hela%20karyotype%203%20(1000x).jpg karyotype http://www.ucl.ac.uk/~ucbhjow/medicine/images/human_karyotype.gif
More informationToday. Genomic Imprinting & X-Inactivation
Today 1. Quiz (~12 min) 2. Genomic imprinting in mammals 3. X-chromosome inactivation in mammals Note that readings on Dosage Compensation and Genomic Imprinting in Mammals are on our web site. Genomic
More informationBioinformatics Laboratory Exercise
Bioinformatics Laboratory Exercise Biology is in the midst of the genomics revolution, the application of robotic technology to generate huge amounts of molecular biology data. Genomics has led to an explosion
More informationWHEN DO MUTATIONS OCCUR?
WHEN DO MUTATIONS OCCUR? While most DNA replicates with fairly high accuracy, mistakes do happen. DNA polymerase sometimes inserts the wrong nucleotide or too many or too few nucleotides into a sequence.
More informationp.arg119gly p.arg119his p.ala179thr c.540+1g>a c.617_633+6del Prediction basis structure
a Missense ATG p.arg119gly p.arg119his p.ala179thr p.ala189val p.gly206trp p.gly206arg p.arg251his p.ala257thr TGA 5 UTR 1 2 3 4 5 6 7 3 UTR Splice Site, Frameshift b Mutation p.gly206trp p.gly4fsx50 c.138+1g>a
More informationEarly Embryonic Development
Early Embryonic Development Maternal effect gene products set the stage by controlling the expression of the first embryonic genes. 1. Transcription factors 2. Receptors 3. Regulatory proteins Maternal
More informationDifferentiation-induced Changes of Mediterranean Fever Gene (MEFV) Expression in HL-60 Cell
Differentiation-induced Changes of Mediterranean Fever Gene (MEFV) Expression in HL-60 Cell Wenxin Li Department of Biological Sciences Fordham University Abstract MEFV is a human gene that codes for an
More informationNALP12, a gene responsible for periodic fever syndromes. Isabelle Jéru INSERM U.654, Paris, FRANCE
NALP12, a gene responsible for periodic fever syndromes Isabelle Jéru INSERM U.654, Paris, FRANCE Hereditary periodic fever syndromes (HPFs) Phenotype 6 clinical entities Fever episodes Abdominal pain
More information